TD ASSET MANAGEMENT INC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$171,642
-60.6%
31,494
-51.5%
0.00%
Q2 2023$436,049
-30.9%
64,985
-9.1%
0.00%
-100.0%
Q1 2023$631,213
-9.3%
71,485
-21.5%
0.00%0.0%
Q4 2022$696,149
+11.6%
91,1190.0%0.00%0.0%
Q3 2022$624,000
-15.3%
91,1190.0%0.00%0.0%
Q2 2022$737,000
-41.7%
91,1190.0%0.00%0.0%
Q1 2022$1,265,000
-75.0%
91,119
-49.4%
0.00%
-75.0%
Q4 2021$5,053,000
+23.9%
180,072
+50.1%
0.00%0.0%
Q3 2021$4,078,000
-2.5%
119,972
+5.2%
0.00%0.0%
Q2 2021$4,182,000
+3.5%
114,072
+13.6%
0.00%
-20.0%
Q1 2021$4,041,000
+5.7%
100,375
+55.2%
0.01%0.0%
Q4 2020$3,823,000
+69.2%
64,656
+39.2%
0.01%
+66.7%
Q3 2020$2,259,000
+0.5%
46,4560.0%0.00%0.0%
Q2 2020$2,248,000
+78.4%
46,456
+2.4%
0.00%
+50.0%
Q1 2020$1,260,000
+56.9%
45,356
+69.0%
0.00%
+100.0%
Q4 2019$803,000
+3.3%
26,832
+6.8%
0.00%0.0%
Q3 2019$777,00025,1320.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders